Registry of patients with atrial fibrillation undergoing catheter-based ablation
Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry
This study is tracking patients with atrial fibrillation who are getting a specific heart procedure to see how well it works over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 2 sites (Basel and 1 other locations) |
| Trial ID | NCT03718364 on ClinicalTrials.gov |
What this trial studies
This registry collects data from patients with atrial fibrillation who are undergoing catheter-based ablation, specifically focusing on pulmonary vein isolation. The aim is to determine the long-term success rates of this procedure and to evaluate various factors that may influence these outcomes. By tracking patient progress and outcomes over time, the registry seeks to provide valuable insights into the effectiveness of catheter-based ablation for atrial fibrillation. This observational approach allows for a comprehensive understanding of real-world results in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients who are undergoing catheter-based ablation for atrial fibrillation.
Not a fit: Patients who are not able or willing to participate in the study will not benefit from the findings.
Why it matters
Potential benefit: If successful, this registry could provide critical information that enhances the treatment strategies for patients with atrial fibrillation, potentially leading to improved long-term outcomes.
How similar studies have performed: Other studies have shown success with similar observational approaches in evaluating the effectiveness of catheter-based ablation for atrial fibrillation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) Exclusion Criteria: * Patients not able or willing to participate in this study
Where this trial is running
Basel and 1 other locations
- Cardiology/Electrophysiology, University Hospital Basel — Basel, Switzerland (Recruiting)
- University Hospital Bern — Bern, Switzerland (Recruiting)
Study contacts
- Principal investigator: Michael Kuehne, MD — Cardiology/Electrophysiology, University Hospital Basel
- Study coordinator: Michael Kuehne, MD
- Email: michael.kuehne@usb.ch
- Phone: +41 61 328 74 71
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.